Erratum: Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion (Journal of Experimental Medicine (2010) 207:3 DOI: 10.1084/jem.20090397);Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion

Journal of Experimental Medicine

Volumn 207, Issue 3, 2010, Pages 505-520

  Huang, Xiaoyuan ^a   Bai, Xiangyang ^a   Cao, Yang ^a   Wu, Jingyi ^a   Huang, Mei ^a   Tang, Duozhuang ^a   Tao, Si ^a   Zhu, Tao ^a   Liu, Yanling ^a   Yang, Yang ^a   Zhou, Xiaoxi ^a   Zhao, Yanxia ^a   Wu, Mingfu ^a   Wei, Juncheng ^a   Wang, Daowen ^a   Xu, Gang ^a   Wang, Shixuan ^a   Ma, Ding ^a   Zhou, Jianfeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CELL PROTEIN; INTERLEUKIN 6; PROTEIN TIM 3; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CELL INTERACTION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; ENDOTHELIUM; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IN SITU HYBRIDIZATION; LYMPHOMA; METASTASIS; MICRODISSECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; WESTERN BLOTTING;

EID: 77949524521     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.2009039703042021c     Document Type: Erratum

References (40)

1. Bai, X., M. Huang, J. Wu, X. Huang, L. Yan, Y. Lu, S. Wang, G. Xu, J. Zhou, and D. Ma. 2008. Development and characterization of a novel method to analyze global gene expression profiles in endothelial cells derived from primary tissues. Am. J. Hematol. 83:26-33. doi:10.1002/ajh.20953
2. Bruns, I., F. Fox, P. Reinecke, G. Kobbe, R. Kronenwett, G. Jung, and R. Haas. 2005. Complete remission in a patient with relapsed angio-immunoblastic T-cell lymphoma following treatment with bevacizumab. Leukemia. 19:1993-1995. doi:10.1038/sj.leu.2403936
3. Choi, J., D.R. Enis, K.P. Koh, S.L. Shiao, and J.S. Pober. 2004. T lymphocyte-endothelial cell interactions. Annu. Rev. Immunol. 22: 683-709. doi:10.1146/annurev.immunol.22.012703.104639
4. Cooke, B.M., S. Usami, I. Perry, and G.B. Nash. 1993. A simplified method for culture of endothelial cells and analysis of adhesion of blood cells under conditions of flow. Microvasc. Res. 45:33-45. doi:10.1006/mvre.1993.1004
5. Coupel, S., F. Leboeuf, G. Boulday, J.P. Soulillou, and B. Charreau. 2004. RhoA activation mediates phosphatidylinositol 3-kinase-dependent proliferation of human vascular endothelial cells: an alloimmune mechanism of chronic allograft nephropathy. J. Am. Soc. Nephrol. 15:2429-2439. doi:10.1097/01.ASN.0000138237.42675.45
6. Coventry, B.J., and J. Morton. 2003. CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer. Br. J. Cancer. 89:533-538. doi:10.1038/sj.bjc.6601114
7. Danese, S., E. Dejana, and C. Fiocchi. 2007. Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J. Immunol. 178:6017-6022.
8. Fidler, I.J., and L.M. Ellis. 2004. Neoplastic angiogenesis-not all blood vessels are created equal. N. Engl. J. Med. 351:215-216. doi:10.1056/NEJMp048080
9. Gao, Q., X. Huang, D. Tang, Y. Cao, G. Chen, Y. Lu, L. Zhuang, S. Wang, G. Xu, J. Zhou, and D. Ma. 2006. Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells. Apoptosis. 11:1789-1800. doi:10.1007/s10495-006-9421-4
10. Gao, D., D.J. Nolan, A.S. Mellick, K. Bambino, K. McDonnell, and V. Mittal. 2008. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science. 319:195-198. doi:10.1126/science.1150224
11. Geng, H., G.M. Zhang, D. Li, H. Zhang, Y. Yuan, H.G. Zhu, H. Xiao, L.F. Han, and Z.H. Feng. 2006. Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J. Immunol. 176:1411-1420.
12. Göthert, J.R., S.E. Gustin, J.A. van Eekelen, U. Schmidt, M.A. Hall, S.M. Jane, A.R. Green, B. Göttgens, D.J. Izon, and C.G. Begley. 2004. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood. 104:1769-1777. doi:10.1182/blood-2003-11-3952
13. Gunsilius, E., H.C. Duba, A.L. Petzer, C.M. Kähler, K. Grünewald, G. Stockhammer, C. Gabl, S. Dirnhofer, J. Clausen, and G. Gastl. 2000. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet. 355:1688-1691. doi:10.1016/S0140-6736(00)02241-8
14. Karnoub, A.E., A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, G.W. Bell, A.L. Richardson, K. Polyak, R. Tubo, and R.A. Weinberg. 2007. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 449:557-563. doi:10.1038/nature06188
15. Kim, R., M. Emi, K. Tanabe, and K. Arihiro. 2006. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res. 66:5527-5536. doi:10.1158/0008-5472.CAN-05-4128
16. Koster, A., and J.M. Raemaekers. 2005. Angiogenesis in malignant lymphoma. Curr. Opin. Oncol. 17:611-616. doi:10.1097/01.cco.0000181404 .83084.b5
17. Kuchroo, V.K., D.T. Umetsu, R.H. DeKruyff, and G.J. Freeman. 2003. The TIM gene family: emerging roles in immunity and disease. Nat. Rev. Immunol. 3:454-462. doi:10.1038/nri1111
18. Lenz, G., G. Wright, S.S. Dave, W. Xiao, J. Powell, H. Zhao, W. Xu, B. Tan, N. Goldschmidt, J. Iqbal, et al. 2008. Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med. 359:2313-2323.
19. Maloney, D.G. 2005. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines. J. Clin. Oncol. 23:6421-6428. doi:10.1200/JCO.2005.06.004
20. Neri, D., and R. Bicknell. 2005. Tumour vascular targeting. Nat. Rev. Cancer. 5:436-446. doi:10.1038/nrc1627
21. Nobumoto, A., K. Nagahara, S. Oomizu, S. Katoh, N. Nishi, K. Takeshita, T. Niki, A. Tominaga, A. Yamauchi, and M. Hirashima. 2008. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices. Glycobiology. 18:735-744. doi:10.1093/glycob/cwn062
22. Padua, R.A., J. Larghero, M. Robin, C. le Pogam, M.H. Schlageter, S. Muszlak, J. Fric, R. West, P. Rousselot, T.H. Phan, et al. 2003. PMLRARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia. Nat. Med. 9:1413-1417. doi:10.1038/nm949
23. Pezzolo, A., F. Parodi, M.V. Corrias, R. Cinti, C. Gambini, and V. Pistoia. 2007. Tumor origin of endothelial cells in human neuroblastoma. J. Clin. Oncol. 25:376-383. doi:10.1200/JCO.2006.09.0696
24. Rice, J., T. Elliott, S. Buchan, and F.K. Stevenson. 2001. DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines. J. Immunol. 167:1558-1565.
25. Rigolin, G.M., C. Fraulini, M. Ciccone, E. Mauro, A.M. Bugli, C. De Angeli, M. Negrini, A. Cuneo, and G. Castoldi. 2006. Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood. 107:2531-2535. doi:10.1182/blood-2005-04-1768
26. Sabatos, C.A., S. Chakravarti, E. Cha, A. Schubart, A. Sánchez-Fueyo, X.X. Zheng, A.J. Coyle, T.B. Strom, G.J. Freeman, and V.K. Kuchroo. 2003. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4:1102-1110. doi:10.1038/ni988
27. Sánchez-Fueyo, A., J. Tian, D. Picarella, C. Domenig, X.X. Zheng, C.A. Sabatos, N. Manlongat, O. Bender, T. Kamradt, V.K. Kuchroo, et al. 2003. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4: 1093-1101. doi:10.1038/ni987
28. Shih, S.C., and K.P. Claffey. 1999. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J. Biol. Chem. 274:1359-1365. doi:10.1074/jbc.274.3. 1359
29. Song, D., S. Sakamoto, and T. Taniguchi. 2002. Inhibition of poly(ADPribose) polymerase activity by Bcl-2 in association with the ribosomal protein S3a. Biochemistry. 41:929-934. doi:10.1021/bi015669c
30. Steeg, P.S., and D. Theodorescu. 2008. Metastasis: a therapeutic target for cancer. Nat. Clin. Pract. Oncol. 5:206-219. doi:10.1038/ncponc1066
31. Streubel, B., A. Chott, D. Huber, M. Exner, U. Jäger, O. Wagner, and I. Schwarzinger. 2004. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N. Engl. J. Med. 351:250-259. doi:10.1056/NEJMoa033153
32. Sun, Y., M. Song, E. Jäger, C. Schwer, S. Stevanovic, S. Flindt, J. Karbach, X.D. Nguyen, D. Schadendorf, and K. Cichutek. 2008. Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR. Clin. Cancer Res. 14: 4306-4315. doi:10.1158/1078-0432.CCR-07-4849
33. Tiemessen, M.M., A.L. Jagger, H.G. Evans, M.J. van Herwijnen, S. John, and L.S. Taams. 2007. CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA. 104:19446-19451. doi:10.1073/pnas .0706832104
34. van Dongen, J.J., A.W. Langerak, M. Brüggemann, P.A. Evans, M. Hummel, F.L. Lavender, E. Delabesse, F. Davi, E. Schuuring, R. García-Sanz, et al. 2003. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 17:2257-2317. doi:10.1038/sj.leu. 2403202
35. van Krieken, J.H., A.W. Langerak, E.A. Macintyre, M. Kneba, E. Hodges, R.G. Sanz, G.J. Morgan, A. Parreira, T.J. Molina, J. Cabeçadas, et al. 2007. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 21:201-206. doi:10.1038/sj.leu.2404467
36. Weidner, N. 1995. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147:9-19.
37. Wong, O.H., F.P. Huang, and A.K. Chiang. 2005. Differential responses of cord and adult blood-derived dendritic cells to dying cells. Immunology. 116:13-20. doi:10.1111/j.1365-2567.2005.02191.x
38. Wu, J., L. Huang, M. Huang, W. Liu, M. Zheng, Y. Cao, Y. Liu, Y. Zhang, Y. Lu, G. Xu, et al. 2009. Dominant contribution of malignant endothelial cells to endotheliopoiesis in chronic myeloid leukemia. Exp. Hematol. 37:87-91. doi:10.1016/j.exphem.2008.08.009
39. Zhou, J., Q. Gao, G. Chen, X. Huang, Y. Lu, K. Li, D. Xie, L. Zhuang, J. Deng, and D. Ma. 2005. Novel oncolytic adenovirus selectively targets tumor-associated polo-like kinase 1 and tumor cell viability. Clin. Cancer Res. 11:8431-8440. doi:10.1158/1078-0432.CCR-05-1085
40. Zhu, C., A.C. Anderson, A. Schubart, H. Xiong, J. Imitola, S.J. Khoury, X.X. Zheng, T.B. Strom, and V.K. Kuchroo. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6:1245-1252. doi:10.1038/ni1271